Opdivo

$2,872.00 $1,250.00

Opdivo, is a medication used to treat cancer. It is used as a first-line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma. We help patients and doctors get access to medicines at the lowest price worldwide.

OncologyUrothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
Mode of ActionMonoclonal antibody (immunotherapy)
AdministrationIntravenous
Regulatory agency approvalEuropean Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA, Pharmaceuticals and Medical Devices Agency (PMDA), Japan, Therapeutic Goods Administration (TGA), Australia
Strength10 milligram / millilitre
Package1 Vials
Clear
×